Check Psyence Biomedical Equity Warrants Exp 22 Jan 2029 market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.9M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0Return On Equity TTM
1491500.00%
Compare market cap, revenue, PE, and other key metrics of Psyence Biomedical Equity Warrants Exp 22 Jan 2029 with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
NA | $6.9M | NA | NA | 0.00% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Psyence Biomedical Equity Warrants Exp 22 Jan 2029 investment value today
Current value as on today
₹3,04,953
Returns
₹2,04,953
(+204.95%)
Returns from Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock
₹2,00,000 (+200%)
Dollar Returns*
₹4,953 (+4.95%)
Investment in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Shares on INDmoney has grown by 60.39% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:60.39% versus previous 30 day period
Search interest for Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock has increased by 77% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:77% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Beone Medicines Ltd has given 67.3% return, outperforming this stock by 2.7%
Price Dip
In the last 7 days, PBMWW stock has moved down by -18.0%
Organisation | Psyence Biomedical Equity Warrants Exp 22 Jan 2029 |
Headquarters | 121 Richmond Street West, Toronto, ON, Canada, M5H2K1 |
CEO | Dr. Neil Maresky M.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Taryn Vos | General Counsel |
Mr. Jody Aufrichtig | Co-Founder, Executive Chairman & Strategic Business Development Officer |
Dr. Neil Maresky M.D. | CEO & Director |
Mr. Warwick Ron Corden-Lloyd | Chief Financial Officer |
Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share price today is $0.03 as on at the close of the market. Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share today touched a day high of $0.03 and a low of $0.02.
Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share touched a 52 week high of $0.05 on and a 52 week low of $0 on . Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stock price today i.e. is closed at $0.03,which is 37.63% down from its 52 week high and 733.33% up from its 52 week low.
Psyence Biomedical Equity Warrants Exp 22 Jan 2029 market capitalisation is $0.00T as on .
Indian investors can start investing in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 (PBMWW) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stock (as per the Rupee-Dollar exchange rate as on ).
Based on Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share’s latest price of $0.03 as on September 19, 2025 at 1:10 am IST, you will get 333.3333 shares of Psyence Biomedical Equity Warrants Exp 22 Jan 2029. Learn more about
fractional shares .